Back to Markets
CRCorMedix Inc

CorMedix Inc

CRMDNASDAQ NMS - GLOBAL MARKET
Health CarePharmaceuticals

$8.44

+0.0200 (+0.24%)

As of 05/29/26 EDT · USD

Compare
Low: $6.13Current: $8.44High: $17.43

Key Statistics

Open

$8.41

Day High

$8.48

Day Low

$8.26

Prev. Close

$8.42

VolumeShares traded today.

990.34K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$662.13M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

3.99

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$17.43

52W LowLowest price over the past 52 weeks.

$6.13

50D MAAverage closing price over the last 50 trading days.

$7.43

200D MAAverage closing price over the last 200 trading days.

$9.52

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+4.7%

1M

+12.8%

6M

-10.2%

YTD

-30.6%

1Y

-30.5%

About

Taurolidine/heparin, sold under the brand name Defencath, is a fixed-dose combination catheter lock solution used for central venous catheter instillation. It contains taurolidine, a thiadiazinane antimicrobial; and heparin, an anti-coagulant. Its use is limited to people with kidney failure receiving chronic hemodialysis through a central venous catheter.

cormedix.com/

Company Facts

SectorHealth Care
IndustryPharmaceuticals
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CRMD

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.